Enzo Life Sciences
Enzo Life Sciences is a recognized leader in technologies for cellular analysis, assay development, molecular biology, and proteostasis. Our diverse portfolio of fluorescent labels & dyes, ELISA and enzyme activity assays, biochemicals, antibodies, and proteins serves the life sciences research, drug discovery & development, and clinical research markets. Our products facilitate discovery in cancer, neuroscience, cellular stress, immunology, screening and lead identification, toxicology, bioprocess optimization, and clinical diagnostics.
We are scientists enabling scientists™. For over 30 years, Enzo Life Sciences has been providing the life sciences market with a unique array of fluorescent probes, dyes, and labeling systems for molecular biology and cellular analysis. Our acquisition of ALEXIS® Biochemicals, BIOMOL® International, Assay Designs® and Stressgen® Bioreagents has incorporated the skills and scientific expertise of these industry-established providers of bioreagents, chemicals, and assay kits.
Enzo Life Sciences now offers a diverse portfolio of over 9000 products and services including: more than 300 immunoassay and enzyme activity assays for biomarker quantification and compound screening; compound libraries composed from our collection of over 3500 chemical compounds including FDA approved drugs, known bioactives, natural products, and pathway-targeted collections; a broad portfolio of innovative CELLestial® assay kits for live cell analysis, including kits for early assessment of in vitro cytotoxicity and ProteoStat® dyes for detection of protein aggregates; robust array cGH labeling kits for detecting DNA copy number gains and losses; and custom services, featuring contract assay development backed by our assay development and manufacturing expertise and world class reagents.
No reviews to display
First-to-market, sensitive ELISA kit to quantify APP ΔC31, an important amyloid precursor protein fragment with a unique pro-apoptotic mechanism lea...
More about the APP ΔC31 ELISA Kit
New APP ΔC31 ELISA Kit from Enzo Life Sciences for the Quantification of a Novel APP Cleavage Fragment Associated with Alzheimer’s Disease
18 Feb 2014
Enzo Now Offer Sensitive KIM-1 ELISA Kit for Quantifying Biomarker of Early Stage Kidney Injury and Disease
16 Dec 2013
New Grp78/BiP ELISA Kit from Enzo Life Sciences, Inc. Quantifies Critical ER Chaperone and Regulator of Unfolded Protein Response
20 Nov 2013
Enzo Life Sciences Display High Efficiency Labeling, Detection, and Modulation Products at Biotechnica 2013
02 Oct 2013
23 Sep 2013